Merck warns doctors to stop prescribing Tredaptive

by The Associated Press

Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.

Tredaptive is available in about 70 countries, including Europe. The drug is not approved in the United States.

Merck last month said initial results from a late-stage study showed that adding Tredaptive to traditional did not lower the risk of heart attack, stroke and related problems.

Results also showed that patients taking the cholesterol were more likely to suffer some serious, non-fatal adverse events.

Merck says it made its decision based in part on a European Medicine Agency committee recommendation.

Merck has advised patients to quit taking the drug only after talking to a physician.

0 shares

Related Stories

Merck says cholesterol drug failed to show benefit

date Dec 20, 2012

Drugmaker Merck & Co. said it will not seek U.S. approval for its cholesterol drug Tredaptive and is recommending doctors abroad stop prescribing it to new patients, based on failed study results.

FDA backs Vytorin for kidney disease patients

date Oct 31, 2011

(AP) -- The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug.

FDA to review Vytorin results

date Jan 26, 2008

The U.S. Food and Drug Administration said it is conducting a review of the cholesterol drug Vytorin based on preliminary results from a recent study.

Recommended for you

FDA warns of bogus botox

date 11 hours ago

(HealthDay)—Counterfeit Botox may have been distributed to doctors' offices and medical clinics across the United States, the U.S. Food and Drug Administration warns.

Fake malaria drugs not as common as previously reported

date 17 hours ago

A rigorous analysis of antimalarial drug quality conducted in Cambodia and Tanzania found no evidence of fake medicines, according to new research published in the American Journal of Tropical Medicine and Hygiene.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.